Professional
Added to YB: 2026-07-30
Pitch date: 2026-07-27
VISN [neutral]
Gyroscope Therapeutics Holdings PLC
Author Info
LVS Advisory is a boutique investment firm focused on providing active investment management services for individuals, families, and institutions. Sign up for the newsletter.
Company Info
As of February 18, 2022, operates as a subsidiary of Novartis AG.
Market Cap
N/A
Pitch Price
N/A
Price Target
18.00
Dividend
N/A
EV/EBITDA
N/A
P/E
N/A
EV/Sales
N/A
Sector
Biotechnology
Category
special_situation
LVS Advisory Portfolio Holding: Vistance Networks, Inc.
VISN (holding update): Busted telecom roll-up (ex-CommScope). Sold CCS to Amphenol $10.5B, paid off debt + $10/sh special div; Ruckus sold for $1.8B. Bought at $13.52, now $12.13 w/ ~$8/sh cash pending payout + remainco doing ~$0.90 FCF/sh (~4.4x). Values remainco $6-8, stock worth $14-18. Paid $13.52 for $24-28 value in <1yr; likely final asset sale soon.
Read full article (2 min)